Covestor’s KALA BIO KALA Stock Holding History

Covestor’s Portfolio KALA Stock Details KALA Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q1	$0	Hold	25	–	–	﹤0.01%	2530
2025 Q4	$1K	Hold	25	–	–	﹤0.01%	2087
2025 Q3	$2K	Buy	25 +2	+9%	+$992	﹤0.01%	1959
2025 Q2	$5K	Hold	23	–	–	﹤0.01%	1751
2025 Q1	$7K	Buy	23 +4	+21%	+$1.51K	﹤0.01%	1667
2024 Q4	$7K	Hold	19	–	–	﹤0.01%	1663
2024 Q3	$6K	Sell	19 -2	-10%	-$631	﹤0.01%	1713
2024 Q2	$7K	Hold	21	–	–	﹤0.01%	1716
2024 Q1	$8K	Sell	21 -4	-16%	-$1.49K	0.01%	1706
2023 Q4	$9K	Sell	25 -2	-7%	-$708	0.01%	1643
2023 Q3	$12K	Buy	27 +15	+125%	+$9.84K	0.01%	1327
2023 Q2	$9K	Buy	12 +8	+200%	+$6.21K	0.01%	1509
2023 Q1	$3K	Hold	4	–	–	﹤0.01%	1684
2022 Q4	$8K	Sell	4 -1	-20%	-$396	0.01%	1422
2022 Q3	$3K	Hold	5	–	–	﹤0.01%	1621
2022 Q2	$4K	Sell	5 -1	-17%	-$1.57K	﹤0.01%	1471
2022 Q1	$19K	Sell	6 -1	-14%	-$2.62K	0.01%	1078
2021 Q4	$21K	Buy	+7	New	+$32.5K	0.03%	848

Other funds holding KALA

Renaissance Technologies New York $63.9B AUM 45.56% 1-Year Est. Return

Citadel Advisors Miami, Florida $618B AUM 30.34% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return

Virtu Financial New York $2.41B AUM 48.35% 1-Year Est. Return

ACM

ADAR1 Capital Management Austin, Texas $1.7B AUM 340.85% 1-Year Est. Return

GCP

GSA Capital Partners London, United Kingdom $1.61B AUM 28.28% 1-Year Est. Return

UBS Group Zurich, Switzerland $666B AUM 30.12% 1-Year Est. Return

VCM

Vanguard Capital Management Malvern, Pennsylvania $4.04T AUM

Jane Street New York $777B AUM 61.18% 1-Year Est. Return

JP Morgan Chase New York $1.56T AUM 27.86% 1-Year Est. Return

Covestor's KALA Position: Q1 2026 in Review

Covestor held its KALA BIO (KALA) position steady in Q1 2026 at 25 shares worth $0. The position accounts for ﹤0.01% of the portfolio, ranked #2530.

Covestor first reported a position in KALA in Q4 2021 and has held it in 18 quarters since. The position peaked at $21K in Q4 2021. 28 funds tracked by Wall St. Rank hold KALA as of Q1 2026.

Covestor held 25 shares of KALA BIO worth $0 as of Q1 2026.
Covestor left its KALA BIO share count unchanged in Q1 2026.
KALA BIO made up ﹤0.01% of Covestor's portfolio in Q1 2026, its #2530 holding.
Covestor first reported a position in KALA BIO in Q4 2021 and has held it in 18 quarters since.
Covestor's KALA BIO position peaked at $21K in Q4 2021.
28 funds tracked by Wall St. Rank held KALA BIO as of Q1 2026.

Based on Covestor's 13F filing for Q1 2026, filed 5 May 2026.